Yen-Peng Li

Title: Innovations and Contributions of Yen-Peng Li

Introduction

Yen-Peng Li is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of protein fragments and biomarkers associated with liver fibrosis. With a total of 5 patents, his work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

One of Yen-Peng Li's latest patents is a method of detecting a urine protein fragment and a serum protein fragment. This method describes the detection of specific protein fragments in urine and serum samples obtained from the same individual. The protein fragments include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, and serum osteopontin. Another significant patent focuses on identifying biomarkers useful in liver fibrosis diagnosis. This patent highlights the identification of urokinase-type plasminogen, matrix metalloproteinase 9, and β-2-microglobulin as novel biomarkers associated with liver fibrosis, which can aid in diagnosing and staging the condition.

Career Highlights

Yen-Peng Li has worked with prominent organizations such as the Industrial Technology Research Institute and Bio Preventive Medicine Corporation. His experience in these institutions has allowed him to develop innovative solutions in the medical field.

Collaborations

Throughout his career, Yen-Peng Li has collaborated with talented individuals, including Tzu-Ling Tseng and Hung-Yi Li. These collaborations have contributed to the advancement of research and development in his areas of expertise.

Conclusion

Yen-Peng Li's contributions to medical diagnostics through his patents and collaborations demonstrate his commitment to innovation in healthcare. His work continues to pave the way for advancements in the detection and diagnosis of critical health conditions.